{"product_id":"tumotest","title":"TumoTest™ - Circulating Tumor Cell Test","description":"\u003cp\u003e\u003cstrong\u003eTumoTest™\u003c\/strong\u003e is an advanced blood-based circulating tumor cell test designed for confirmed cancer patients who require deeper cancer monitoring, treatment-response tracking, and personalized oncology planning.\u003c\/p\u003e\n\u003cp\u003eCancer is not only defined by the tumour seen on imaging. In many cases, cancer-related cells may circulate in the bloodstream and provide important information about disease activity, tumour behaviour, aggressiveness, and possible response to ongoing treatment.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is developed to help doctors better understand what is happening beyond conventional scans and tumour markers by analysing circulating tumor cells, also known as CTCs, from a blood sample.\u003c\/p\u003e\n\u003cp\u003eThis makes TumoTest™ a valuable monitoring tool for patients undergoing doctor-led cancer management.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT \u003cmeta charset=\"utf-8\"\u003eTUMOTEST™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is a \u003cstrong\u003eCirculating Tumor Cell Test.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCirculating Tumor Cells, or CTCs, are cancer-related cells that may detach from a primary tumour or metastatic site and enter the bloodstream.\u003c\/p\u003e\n\u003cp\u003eBy analysing these cells, TumoTest™ helps provide additional insight into:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer-cell presence in circulation\u003c\/li\u003e\n\u003cli\u003ecancer-cell characteristics\u003c\/li\u003e\n\u003cli\u003etumour behaviour\u003c\/li\u003e\n\u003cli\u003edisease activity\u003c\/li\u003e\n\u003cli\u003etreatment response\u003c\/li\u003e\n\u003cli\u003epossible aggressiveness\u003c\/li\u003e\n\u003cli\u003emetastatic potential\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eTumoTest™ helps detect and study cancer-related cells circulating in the blood.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is not a general cancer screening test for healthy individuals. It is mainly designed for patients with \u003cstrong\u003econfirmed cancer diagnosis\u003c\/strong\u003e or patients under doctor-led oncology monitoring.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW TUMOTEST™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a blood sample.\u003c\/p\u003e\n\u003cp\u003eThe sample is analysed to identify and evaluate circulating tumor cells. These cells may carry useful information about the patient’s current cancer status.\u003c\/p\u003e\n\u003cp\u003eThrough CTC analysis, doctors can obtain a clearer picture of how the cancer may be behaving at that point in time.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may help evaluate:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ewhether circulating tumor cells are present\u003c\/li\u003e\n\u003cli\u003ehow many CTCs are detected\u003c\/li\u003e\n\u003cli\u003ewhether the CTC level is changing over time\u003c\/li\u003e\n\u003cli\u003ewhether cancer-cell characteristics suggest higher or lower activity\u003c\/li\u003e\n\u003cli\u003ewhether treatment appears to be reducing cancer-cell burden\u003c\/li\u003e\n\u003cli\u003ewhether further treatment planning should be considered\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis allows cancer monitoring to become more dynamic, rather than depending only on imaging or routine tumour markers.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHY CIRCULATING TUMOR CELLS MATTER?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCancer cells may not remain only in one location.\u003c\/p\u003e\n\u003cp\u003eSome cancer cells can enter the bloodstream and travel through the body. These circulating tumor cells may provide important biological information about cancer progression, treatment response, and metastatic behaviour.\u003c\/p\u003e\n\u003cp\u003eMonitoring CTCs can help doctors understand whether the cancer appears to be:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eresponding to treatment\u003c\/li\u003e\n\u003cli\u003eremaining active\u003c\/li\u003e\n\u003cli\u003echanging in behaviour\u003c\/li\u003e\n\u003cli\u003eshowing signs of higher aggressiveness\u003c\/li\u003e\n\u003cli\u003erequiring closer monitoring\u003c\/li\u003e\n\u003cli\u003eneeding further investigation or treatment adjustment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTumoTest™ supports this by helping provide a blood-based view of cancer-related cellular activity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES TUMOTEST™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood-Based Cancer Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ uses a blood sample to study circulating tumor cells, offering an additional layer of information beyond conventional tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocuses on Confirmed Cancer Cases\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ is designed for patients with confirmed cancer diagnosis, especially those who need monitoring during or after treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTracks Cancer-Cell Activity\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eInstead of only looking at tumour size, TumoTest™ helps review cancer-cell activity in circulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Response Review\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eA reduction in CTC number or improvement in cancer-cell characteristics may help support the assessment of treatment response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Biological Insight\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ may provide information related to cancer-cell behaviour, including aggressiveness, stemness, and metastatic potential.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help doctors decide whether the patient requires continued monitoring, additional investigation, or further treatment planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitors Circulating Tumor Cells\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps detect and evaluate cancer-related cells circulating in the bloodstream.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Response Tracking\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be used to compare changes before, during, or after treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Additional Insight Beyond Tumour Markers\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eGives doctors another layer of biological information beyond routine blood tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Understand Cancer Behaviour\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay provide information related to tumour aggressiveness, cancer-cell characteristics, and metastatic activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Ongoing Cancer Management\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSupports monitoring in patients undergoing chemotherapy, immunotherapy, targeted therapy, integrative oncology support, or post-treatment follow-up.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Advanced Personalized Care\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be used as part of a broader precision oncology workflow to guide doctor-led decision-making.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO TUMOTEST™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is designed for \u003cstrong\u003econfirmed cancer patients\u003c\/strong\u003e who need advanced monitoring and deeper cancer-cell insight.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eare currently undergoing cancer treatment\u003c\/li\u003e\n\u003cli\u003ehave completed treatment and require monitoring\u003c\/li\u003e\n\u003cli\u003eneed treatment response assessment\u003c\/li\u003e\n\u003cli\u003ehave unclear tumour marker results\u003c\/li\u003e\n\u003cli\u003ewant deeper cancer-cell activity tracking\u003c\/li\u003e\n\u003cli\u003eare being evaluated for personalized oncology support\u003c\/li\u003e\n\u003cli\u003erequire additional information before advanced treatment planning\u003c\/li\u003e\n\u003cli\u003eneed monitoring of disease activity over time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTumoTest™ may be useful in doctor-led cancer management where CTC information can support clearer case understanding.\u003c\/p\u003e\n\u003cp\u003eWHEN TUMOTEST™ MAY BE RECOMMENDED?\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may be considered:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ebefore starting a new treatment plan\u003c\/li\u003e\n\u003cli\u003eduring ongoing cancer treatment\u003c\/li\u003e\n\u003cli\u003eafter chemotherapy, immunotherapy, targeted therapy, or other oncology care\u003c\/li\u003e\n\u003cli\u003ewhen tumour markers are unclear or insufficient\u003c\/li\u003e\n\u003cli\u003ewhen imaging results need additional biological context\u003c\/li\u003e\n\u003cli\u003eduring follow-up monitoring\u003c\/li\u003e\n\u003cli\u003ebefore considering advanced personalized oncology support\u003c\/li\u003e\n\u003cli\u003ewhen doctors need blood-based cancer-cell information\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor patients on active chemotherapy, blood draw timing should be planned carefully under professional guidance, usually during an appropriate gap between treatment cycles.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may provide information such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003epresence of circulating tumor cells\u003c\/li\u003e\n\u003cli\u003eCTC count\u003c\/li\u003e\n\u003cli\u003ecancer-cell characteristics\u003c\/li\u003e\n\u003cli\u003etumour activity indicators\u003c\/li\u003e\n\u003cli\u003echanges compared to previous results\u003c\/li\u003e\n\u003cli\u003epossible treatment-response pattern\u003c\/li\u003e\n\u003cli\u003ebiological signs linked to cancer aggressiveness\u003c\/li\u003e\n\u003cli\u003eindicators that may support further oncology planning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA falling CTC number or improvement in cancer-cell characteristics may help support the impression that a treatment approach is working. However, interpretation must always be done by a qualified medical professional together with imaging, tumour markers, symptoms, and clinical findings.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW TUMOTEST™ SUPPORTS PERSONALIZED ONCOLOGY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEvery cancer behaves differently.\u003c\/p\u003e\n\u003cp\u003eTwo patients with the same diagnosis may have different circulating tumor cell profiles, different response patterns, and different levels of cancer-cell activity.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ helps doctors move beyond a one-size-fits-all view by providing blood-based information on the patient’s actual cancer-cell behaviour.\u003c\/p\u003e\n\u003cp\u003eThis may support more informed decisions on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003emonitoring frequency\u003c\/li\u003e\n\u003cli\u003etreatment response\u003c\/li\u003e\n\u003cli\u003efurther investigation\u003c\/li\u003e\n\u003cli\u003esuitability for advanced oncology support\u003c\/li\u003e\n\u003cli\u003efollow-up planning\u003c\/li\u003e\n\u003cli\u003epersonalized treatment discussion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eSAMPLE \u0026amp; PROFESSIONAL WORKFLOW\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is performed through a professional blood collection process.\u003c\/p\u003e\n\u003cp\u003eThe general workflow may include:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eDoctor consultation and case review\u003c\/li\u003e\n\u003cli\u003eBlood sample collection\u003c\/li\u003e\n\u003cli\u003eSample handling and shipment according to protocol\u003c\/li\u003e\n\u003cli\u003eLaboratory analysis of circulating tumor cells\u003c\/li\u003e\n\u003cli\u003eReport generation\u003c\/li\u003e\n\u003cli\u003eDoctor-led interpretation\u003c\/li\u003e\n\u003cli\u003eFollow-up planning based on the patient’s overall condition\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe result should not be interpreted in isolation. It should be reviewed together with the patient’s diagnosis, imaging reports, tumour markers, current treatment, medications, symptoms, and overall clinical status.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is a circulating tumor cell test intended for professional use and doctor-led interpretation.\u003c\/p\u003e\n\u003cp\u003eIt is not intended to diagnose cancer as a standalone test, treat cancer, cure cancer, or prevent cancer. Results must be interpreted by qualified medical professionals and reviewed together with the patient’s clinical history, imaging, laboratory findings, treatment status, and overall medical condition.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is designed to support cancer monitoring and personalized oncology planning, not replace specialist oncology consultation or standard medical care.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191440961572,"sku":"CTTUMO0075","price":4999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMTumoTest01_6f2e1f3a-9a64-456c-aade-00c8407d6f7f.jpg?v=1779183574","url":"https:\/\/shop.cytolifeasia.com\/zh\/products\/tumotest","provider":"CytoLife","version":"1.0","type":"link"}